Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 535

1.

The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.

Abbott JJ, Oliveira AM, Nascimento AG.

Am J Surg Pathol. 2006 Apr;30(4):436-43.

PMID:
16625088
2.
3.

Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ.

Cancer. 2000 Jun 15;88(12):2711-20.

PMID:
10870053
5.

Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.

Reimann JD, Fletcher CD.

Am J Surg Pathol. 2007 Sep;31(9):1371-7.

PMID:
17721193
6.

Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.

Díaz-Cascajo C, Weyers W, Borrego L, Iñarrea JB, Borghi S.

Am J Dermatopathol. 1997 Dec;19(6):562-7.

PMID:
9415611
7.

CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.

Goldblum JR.

Arch Pathol Lab Med. 1995 Mar;119(3):238-41.

PMID:
7534057
8.

Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.

Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM.

Am J Surg Pathol. 2003 Jan;27(1):27-39.

PMID:
12502925
9.

Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.

Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, Kobayashi C, Oda S, Iwamoto Y, Tsuneyoshi M.

Hum Pathol. 2004 Feb;35(2):240-5.

PMID:
14991543
10.
11.
12.
13.
14.

Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.

Erdem O, Wyatt AJ, Lin E, Wang X, Prieto VG.

Am J Dermatopathol. 2012 Feb;34(1):24-34. doi: 10.1097/DAD.0b013e3182120671.

PMID:
21785324
15.

Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.

Mentzel T, Schärer L, Kazakov DV, Michal M.

Am J Dermatopathol. 2007 Oct;29(5):443-8.

PMID:
17890911
16.

Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.

Llombart B, Monteagudo C, Sanmartín O, López-Guerrero JA, Serra-Guillén C, Poveda A, Jorda E, Fernandez-Serra A, Pellín A, Guillén C, Llombart-Bosch A.

J Am Acad Dermatol. 2011 Sep;65(3):564-75. doi: 10.1016/j.jaad.2010.06.020. Epub 2011 May 12.

PMID:
21570152
17.

Dermatofibrosarcoma protuberans: how wide should we resect?

Farma JM, Ammori JB, Zager JS, Marzban SS, Bui MM, Bichakjian CK, Johnson TM, Lowe L, Sabel MS, Wong SL, Douglas Letson G, Messina JL, Cimmino VM, Sondak VK.

Ann Surg Oncol. 2010 Aug;17(8):2112-8. doi: 10.1245/s10434-010-1046-8. Epub 2010 Mar 31.

PMID:
20354798
18.
19.

Fibrosarcomatous change in dermatofibrosarcoma protuberans.

Wrotnowski U, Cooper PH, Shmookler BM.

Am J Surg Pathol. 1988 Apr;12(4):287-93.

PMID:
3354755
20.

[Realization of clinical diagnoses and treatment for dermatofibrosarcoma protuberans].

Cai H, Shi YQ, Wang YN, Zhu HY, Mo SJ.

Zhonghua Wai Ke Za Zhi. 2004 Jun 7;42(11):678-82. Chinese.

PMID:
15329259

Supplemental Content

Support Center